Cardiovascular Endocrinology

Skip Navigation LinksHome > September 2013 - Volume 2 - Issue 3 > Amiodarone-induced thyrotoxicosis after administration of an...
Text sizing:
Cardiovascular Endocrinology:
doi: 10.1097/XCE.0b013e328362e422
Case report

Amiodarone-induced thyrotoxicosis after administration of an intravenous infusion of amiodarone

Tohooloo, Bhavna*; Jhummon, Navina P.*; Qu, Shen

Collapse Box


Amiodarone is a commonly used treatment modality for life-threatening cardiac arrhythmias, with a well-documented side effect of amiodarone-induced thyrotoxicosis (AIT). Most reports on AIT included patients on long-term oral maintenance therapy. However, to our knowledge, there are no reports in the literature of thyrotoxicosis after intravenous infusion of amiodarone. Here, we report the case of a 52-year-old Chinese woman diagnosed with atrial fibrillation who reverted to normal sinus rhythm after an intravenous infusion of amiodarone (1050 mg) and after 4 days developed hyperthyroidism. She was discharged on oral propranolol. One week later, she had to be readmitted as she started to have fever, pain in the throat and vomiting. Physical examination and investigations showed that she had developed subacute thyroiditis, and prompt treatment was administered accordingly. AIT is a dangerous and critical situation for the patient with underlying cardiac abnormalities and needs to be recognized for prompt treatment.

© 2013Wolters Kluwer Health Lippincott Williams Wilkins

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.